All Stories
Follow
Subscribe to aap Implantate AG

aap Implantate AG

ots Ad hoc-Service: aap Implantate AG <DE0005066609> aap Implantate AG: above-average turnover and earnings growth in Q3

Berlin (ots Ad hoc-Service) -

Ad hoc-announcement edited and sent by DGAP. The sender is solely
responsible for the contents of this announcement.
aap Implantate AG:
above-average turnover and earnings growth in Q3
aap Implantate AG, one of the leading German companies in the
biomedical implant sector, reports above-average turnover and
earnings growth in the first nine months of the current financial
year. Turnover was up 75% on the year to DM 13.7 million from DM 7.9
million. Operating income increased to DM 2.6 million from minus DM
200 thousands in the review period. DVFA adjusted group profits could
almost be tripled and increased to DM 1.5 million during the first
nine months of 2000 from 0,5 million in the corresponding period last
year.
The aap board attributed this gratifying business trend to
markedly higher turnover in the R&D-Services business field and to
the expansion of foreign business.
With the further intensification of international sales
activities, especially in China, Japan and the U.S., the continuation
of development projects in the R&D-Services sector, the acquisition
of Coripharm, Mebio and Corimed and the stake in Osartis the
management sees substantial growth potential for the future.
If you have any queries, please contact:
aap Implantate AG
Bruke Seyoum Alemu Gabriele Voßkühler Member of the Board of
Management Investor Relations Finance and Information Technology
Lorenzweg 5 Lorenzweg 5
12099 Berlin 12099 Berlin
Tel: +49 (0)30 / 750 19-170 Tel.: +49 (0)30 / 750 19-133 Fax: +49
(0)30 / 750 19-111 Tel.: +49 (0)30 / 750 19-111
End
Internet: http://recherche.newsaktuell.de

Original content of: aap Implantate AG, transmitted by news aktuell

More stories: aap Implantate AG
More stories: aap Implantate AG